Plain-English translation of NCT07111715 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing whether artificial intelligence can improve the detection of Crohn disease during a capsule endoscopy — a small, swallowable camera that takes pictures of your small intestine. The study will compare how well AI-assisted review of these images compares to the standard method of having a doctor review them. You would undergo this test if standard colonoscopy didn't confirm or rule out Crohn disease.
Standard colonoscopy sometimes doesn't give a clear answer about whether someone has Crohn disease, especially when only the small intestine is involved. This trial aims to see if AI can help doctors spot signs of the disease more accurately and reliably when reviewing capsule endoscopy images.
You likely qualify if…
You likely don't qualify if…
You will complete several questionnaires about how your symptoms affect your daily life, energy levels, and mental health. You will then swallow a small capsule camera that travels through your small intestine, taking pictures as it goes — this capsule naturally passes out of your body in your stool over the next day or two. A computer system with artificial intelligence will help analyze the images to look for signs of Crohn disease, and your results will be compared with standard review methods.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
Italy